Arena Pharmaceuticals (ARNA) Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss

June 8, 2009 7:54 AM EDT Send to a Friend
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced a late-breaking poster presentation of positive results from BLOOM, the first of two pivotal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login